Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005500:Follow-Up Studies; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011859:Radiography; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality
D004317:Doxorubicin